Entrainment of lactose inhalation powders: A study using laser diffraction

European Journal of Pharmaceutical Sciences

Volumn 40, Issue 4, 2010, Pages 352-358

  Watling, C P ^a   Elliott, J A ^a   Cameron, R E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dry powder inhalation; Entrainment; Erosion; Flowability; Fluidisation; Fracture; Lactose; Laser diffraction

Indexed keywords

ALPHA LACTOSE; DRUG CARRIER; AEROSOL; EXCIPIENT; LACTOSE; POWDER;

AEROSOL; AIRFLOW; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRY POWDER; INHALER; LASER DIFFRACTION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; FLOW KINETICS; INHALATIONAL DRUG ADMINISTRATION; KINETICS; LASER; MEDICINAL CHEMISTRY; METERED DOSE INHALER; PHARMACEUTICS; PHARMACOKINETICS; POWDER; PROCEDURES; QUALITY CONTROL; SCANNING ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; EXCIPIENTS; KINETICS; LACTOSE; LASERS; METERED DOSE INHALERS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHARMACOKINETICS; POWDERS; QUALITY CONTROL; RHEOLOGY; TECHNOLOGY, PHARMACEUTICAL;

EID: 77953541086     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.04.009     Document Type: Article

References (18)

1. de Boer A.H., Hagedoorn P., Gjaltema D., Goede J., Frijlink H.W. Air classifier technology (ACT) in dry powder inhalation Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures. International Journal of Pharmaceutics 2003, 260:187-200.
2. Huber G., Wirth K.E. Electrostatically supported surface coating of solid particles in liquid nitrogen for use in dry-powder-inhalers. Powder Technology 2003, 134:181-192.
3. Iida K., Hayakawa Y., Okamoto H., Danjo K., Leuenberger H. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulphate. Chemical & Pharmaceutical Bulletin 2004, 52:350-353.
4. Iida K., Todo H., Okamoto H., Danjo K., Leuenberger H. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed. Chemical & Pharmaceutical Bulletin 2005, 53:431-434.
5. Islam N., Gladki E. Dry powder inhalers (DPIs)-a review of device reliability and innovation. International Journal of Pharmaceutics 2008, 360:1-11.
6. Kawashima Y., Serigano T., Hino T., Yamamoto H., Takeuchi H. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. International Journal of Pharmaceutics 1998, 172:179-188.
7. Malvern The measurement of dry powder inhalers using the Malvern Spraytec. Malvern Application Note 2001.
8. Newman S.P., Clarke S.W. Therapeutic aerosols. I. Physical and practical considerations. Thorax 1983, 38:881-886.
9. Podczeck F. Particle-particle Adhesion in Pharmaceutical Powder Handling 1998, Imperial College Press.
10. Podczeck F. Influence of particle size distribution and surface roughness of carrier particles on the in vitro properties of dry powder inhalations. Aerosol Science and Technology 1999, 31:301-321.
11. Shur J., Harris H., Jones M.D., Kaerger J.S., Price R. Role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations. Pharmaceutical Research 2008, 25:1631-1640.
12. Tuley R., Shrimpton J., Jones M.D., Price R., Palmer M., Prim D. Experimental observations of dry powder inhaler dose fluidisation. International Journal of Pharmaceutics 2008, 358:238-247.
13. Washington C. Particle Size Analysis in Pharmaceutics and Other Industries: Theory and Practice 1992, Ellis Horwood Limited.
14. Young P.M., Edge S., Traini D., Jones M.D., Price R., El-Sabawi D., Urry C., Smith C. Influence of dose on the performance of dry powder inhalation systems. International Journal of Pharmaceutics 2005, 296:26-33.
15. Zeng X.M., Martin G.P., Tee S.K., Marriott C. Role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro. International Journal of Pharmaceutics 1998, 176:99-110.
16. Zeng X.M., Martin G.P., Marriott C., Pritchard J. Influence of carrier morphology on drug delivery by dry powder inhalers. International Journal of Pharmaceutics 2000, 200:93-106.
17. Zeng X.M., Martin G.P., Marriott C. Particulate Interactions in Dry Powder Formulations for Inhalation 2001, Taylor & Francis.
18. Zeng X.M., Martin G.P., Marriott C., Pritchard J. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. Journal of Pharmaceutical Sciences 2001, 90:1424-1434.